Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07085299

Gut Microbiota and Prognostic Outcomes in Intracranial Arterial Stenosis Patients(GROW-ICAS)

Correlation Study Between Gut Microbiota and Prognosis in Patients With Intracranial Arterial Stenosis(GROW-ICAS)

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Nanjing First Hospital, Nanjing Medical University · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers

Summary

GROW-ICAS (Gut microBiota and prOgnostic Outcomes in IntraCranial Arterial Stenosis) is a prospective observational cohort study that enrolls patients with intracranial arterial stenosis to investigate the correlations between their gut microbiota, metabolomic, and transcriptomic profiles and three key clinical domains: functional outcomes, vascular plaque imaging characteristics, and post-stroke non-motor dysfunctions (including cognitive impairment, depression, anxiety, and fatigue).

Conditions

Timeline

Start date
2025-06-01
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2025-07-25
Last updated
2025-07-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07085299. Inclusion in this directory is not an endorsement.